HYDRA

USPTO USPTO 2001 ABANDONED - NO STATEMENT OF USE FILED

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die US-Marke HYDRA wurde als Wortmarke am 08.08.2001 beim Amerikanischen Patent- und Markenamt angemeldet. Der aktuelle Status der Marke ist "ABANDONED - NO STATEMENT OF USE FILED".

Markendetails Letztes Update: 18. Mai 2018

Markenform Wortmarke
Aktenzeichen 76296801
Anmeldedatum 08. August 2001
Veröffentlichungsdatum 27. Dezember 2005

Markeninhaber

790 MEMORIAL DRIVE
02139 CAMBRIDGE
US

Waren und Dienstleistungen

5 Pharmaceuticals preparations for regenerating human tissues and organs, for blocking or promoting vessel development, and for treatment of human disease where the treatment involves generation of, interference with or effects upon one or more signaling molecules, excluding pharmaceutical preparations for the treatment of skin conditions, namely dry skin and eczema; pharmaceutical preparations in the nature of biologicals for regenerating human tissues and organs, for blocking or promoting vessel development, and for treatment of human disease where the treatment involves generation of, interference with or effects upon one or more signaling molecules, excluding pharmaceutical preparations for the treatment of skin conditions, namely dry skin and eczema; and pharmaceutical preparations in the nature of genetic therapies for regenerating human tissues and organs, for blocking or promoting vessel development, and for treatment of human disease where the treatment involves generation of, interference with or effects upon one or more signaling molecules, excluding pharmaceutical preparations for the treatment of skin conditions, namely dry skin and eczema; oral contraceptives; spermicides; tests and assays composed primarily of mammalian cells, ion channels, signaling molecules, dedifferentiated or dedifferentiating cells, and cellular contractile organizational structures for identifying molecules that can induce desirable cardiovascular, reproductive, genitourinary, gastrointestinal, infectious, hematologic, oncologic, metabolic, neurologic, pulmonary, immunologic, renal, rheumatologic, dermatologic or vision results; and tests and assays composed primarily of mammalian cells, ion channels, signaling molecules, dedifferentiated or dedifferentiating cells, and cellular contractile organizational structures for identifying a risk of cardiovascular, reproductive, genitourinary, gastrointestinal, infectious, hematologic, oncologic, metabolic, neurologic, pulmonary, immunologic, renal, rheumatologic, dermatologic and vision diseases
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

ID: 1376296801